BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20937917)

  • 1. Lack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up?
    Carlson CM; Kirby KA; Casadei MA; Partin MR; Kistler CE; Walter LC
    Arch Intern Med; 2011 Feb; 171(3):249-56. PubMed ID: 20937917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of age and comorbidity on colorectal cancer screening among older veterans.
    Walter LC; Lindquist K; Nugent S; Schult T; Lee SJ; Casadei MA; Partin MR
    Ann Intern Med; 2009 Apr; 150(7):465-73. PubMed ID: 19349631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer screening, comorbidity, and follow-up in elderly patients.
    Garman KS; Jeffreys A; Coffman C; Fisher DA
    Am J Med Sci; 2006 Oct; 332(4):159-63. PubMed ID: 17031239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of colorectal cancer screening in veterans based on the location of primary care clinic.
    Malhotra A; Vaughan-Sarrazin M; Charlton ME; Rosenthal GE
    J Prim Care Community Health; 2014 Jan; 5(1):24-9. PubMed ID: 24327586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes following positive fecal occult blood test results in older adults: benefits and burdens.
    Kistler CE; Kirby KA; Lee D; Casadei MA; Walter LC
    Arch Intern Med; 2011 Aug; 171(15):1344-51. PubMed ID: 21555655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs.
    El-Serag HB; Petersen L; Hampel H; Richardson P; Cooper G
    Arch Intern Med; 2006 Nov; 166(20):2202-8. PubMed ID: 17101937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring the quality of colorectal cancer screening: the importance of follow-up.
    Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
    Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization.
    Miglioretti DL; Rutter CM; Bradford SC; Zauber AG; Kessler LG; Feuer EJ; Grossman DC
    Med Care; 2008 Sep; 46(9 Suppl 1):S91-6. PubMed ID: 18725839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.
    Partin MR; Grill J; Noorbaloochi S; Powell AA; Burgess DJ; Vernon SW; Halek K; Griffin JM; van Ryn M; Fisher DA
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):768-76. PubMed ID: 18381474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic testing following fecal occult blood screening in the elderly.
    Lurie JD; Welch HG
    J Natl Cancer Inst; 1999 Oct; 91(19):1641-6. PubMed ID: 10511591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
    Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
    J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers to full colon evaluation for a positive fecal occult blood test.
    Fisher DA; Jeffreys A; Coffman CJ; Fasanella K
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1232-5. PubMed ID: 16775188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result.
    Baig N; Myers RE; Turner BJ; Grana J; Rothermel T; Schlackman N; Weinberg DS
    Am J Gastroenterol; 2003 Sep; 98(9):2078-81. PubMed ID: 14499791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates and correlates of potentially inappropriate colorectal cancer screening in the Veterans Health Administration.
    Powell AA; Saini SD; Breitenstein MK; Noorbaloochi S; Cutting A; Fisher DA; Bloomfield HE; Halek K; Partin MR
    J Gen Intern Med; 2015 Jun; 30(6):732-41. PubMed ID: 25605531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results.
    Partin MR; Gravely AA; Burgess JF; Haggstrom DA; Lillie SE; Nelson DB; Nugent SM; Shaukat A; Sultan S; Walter LC; Burgess DJ
    Cancer; 2017 Sep; 123(18):3502-3512. PubMed ID: 28493543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels and variation in overuse of fecal occult blood testing in the Veterans Health Administration.
    Partin MR; Powell AA; Bangerter A; Halek K; Burgess JF; Fisher DA; Nelson DB
    J Gen Intern Med; 2012 Dec; 27(12):1618-25. PubMed ID: 22810358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of cancer screening: how important is the preventive health examination?
    Fenton JJ; Cai Y; Weiss NS; Elmore JG; Pardee RE; Reid RJ; Baldwin LM
    Arch Intern Med; 2007 Mar; 167(6):580-5. PubMed ID: 17389289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the follow-up of positive hemoccult screening tests: an electronic intervention.
    Humphrey LL; Shannon J; Partin MR; O'Malley J; Chen Z; Helfand M
    J Gen Intern Med; 2011 Jul; 26(7):691-7. PubMed ID: 21327529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of colorectal cancer screening in diverse primary care practices.
    Zimmerman RK; Nowalk MP; Tabbarah M; Grufferman S
    BMC Health Serv Res; 2006 Sep; 6():116. PubMed ID: 16970813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in the management of positive fecal occult blood tests.
    Rao SK; Schilling TF; Sequist TD
    J Gen Intern Med; 2009 Mar; 24(3):356-60. PubMed ID: 19130147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.